Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities
- PMID: 20544321
- PMCID: PMC2947691
- DOI: 10.1007/s11999-010-1398-1
Factors predicting local recurrence, metastasis, and survival in pediatric soft tissue sarcoma in extremities
Abstract
Background: Pediatric soft tissue sarcomas are rare and differ from those in adults regarding the spectrum of diagnoses and treatment. Sarcomas in extremities may have different prognoses from those located elsewhere.
Questions/purposes: We sought risk factors predicting local recurrence, metastasis, and overall survival and asked whether radiation and chemotherapy influenced local recurrence, metastasis, and overall survival.
Methods: We retrospectively reviewed all 98 patients aged 18 years or younger diagnosed with soft tissue sarcomas in extremities from 1990 to 2008. Age, tumor size, depth, location, bone or neurovascular involvement, histologic subtypes, unplanned excision, surgical margins, metastasis at diagnosis, and adjuvant treatments were reviewed for each patient. We determined the effect of each prognostic variable on local recurrence, metastasis, and overall survival.
Results: Ninety-four patients underwent surgical excision and seven patients had local recurrence at a median time of 18.6 months. Radiation therapy reduced the rate of local recurrence. Fourteen patients had metastasis at diagnosis and seven patients later developed metastasis. The median time to metastasis was 20.9 months. Six patients died and the median time to death was 28.0 months. Metastasis at diagnosis was a predictive factor for death.
Conclusions: When limited to extremities, radiation therapy reduced the rate of local recurrence in pediatric soft tissue sarcomas. Metastases at diagnosis predict death.
Figures
Similar articles
-
Clinical and treatment outcomes of planned and unplanned excisions of soft tissue sarcomas.Clin Orthop Relat Res. 2010 Nov;468(11):3028-34. doi: 10.1007/s11999-010-1392-7. Clin Orthop Relat Res. 2010. PMID: 20496020 Free PMC article.
-
What Is the Success of Repeat Surgical Treatment of a Local Recurrence After Initial Wide Resection of Soft Tissue Sarcomas?Clin Orthop Relat Res. 2018 Sep;476(9):1791-1800. doi: 10.1007/s11999.0000000000000158. Clin Orthop Relat Res. 2018. PMID: 30794216 Free PMC article.
-
Do surgical margin and local recurrence influence survival in soft tissue sarcomas?Clin Orthop Relat Res. 2010 Nov;468(11):3003-11. doi: 10.1007/s11999-010-1471-9. Clin Orthop Relat Res. 2010. PMID: 20645035 Free PMC article.
-
[Soft tissue sarcoma: prognostic factors and multimodal treatment].Chirurg. 2000 Jul;71(7):787-94. doi: 10.1007/s001040051137. Chirurg. 2000. PMID: 10986600 Review. German.
-
Brachytherapy in sarcomas.Hematol Oncol Clin North Am. 1995 Aug;9(4):747-63. Hematol Oncol Clin North Am. 1995. PMID: 7490239 Review.
Cited by
-
Score for the Risk and Overall Survival of Lung Metastasis in Patients First Diagnosed With Soft Tissue Sarcoma: A Novel Nomogram-Based Risk Assessment System.Technol Cancer Res Treat. 2022 Jan-Dec;21:15330338211066240. doi: 10.1177/15330338211066240. Technol Cancer Res Treat. 2022. PMID: 35006028 Free PMC article.
-
What are risk factors for local recurrence of deep high-grade soft-tissue sarcomas?Clin Orthop Relat Res. 2012 Mar;470(3):700-5. doi: 10.1007/s11999-011-2017-5. Clin Orthop Relat Res. 2012. PMID: 21826540 Free PMC article.
-
Evaluation of Two Different Approaches for Selecting Patients for Postoperative Radiotherapy in Deep-Seated High-Grade Soft Tissue Sarcomas in the Extremities and Trunk Wall.Cancers (Basel). 2024 Oct 9;16(19):3423. doi: 10.3390/cancers16193423. Cancers (Basel). 2024. PMID: 39410043 Free PMC article.
-
Intraoperative radiation therapy for pediatric sarcomas and other solid tumors.Pediatr Blood Cancer. 2024 Jun;71(6):e30949. doi: 10.1002/pbc.30949. Epub 2024 Mar 22. Pediatr Blood Cancer. 2024. PMID: 38520048 Free PMC article.
-
Indications and clinical outcomes in patients with soft-tissue sarcoma attached to the bone receiving tumorendoprosthetic replacement after tumor resection.Arch Orthop Trauma Surg. 2025 Mar 10;145(1):179. doi: 10.1007/s00402-024-05735-2. Arch Orthop Trauma Surg. 2025. PMID: 40063175 Free PMC article.
References
-
- Bell RS, O’Sullivan B, Liu FF, Powell J, Langer F, Fornasier VL, Cummings B, Miceli PN, Hawkins N, Quirt I, et al. The surgical margin in soft-tissue sarcoma. J Bone Joint Surg Am. 1989;71:370–375. - PubMed
-
- Crist WM, Anderson JR, Meza JL, Fryer C, Raney RB, Ruymann FB, Breneman J, Qualman SJ, Wiener E, Wharam M, Lobe T, Webber B, Maurer HM, Donaldson SS. Intergroup rhabdomyosarcoma study-IV: results for patients with nonmetastatic disease. J Clin Oncol. 2001;19:3091–3102. - PubMed
-
- Ferrari A, Dileo P, Casanova M, Bertulli R, Meazza C, Gandola L, Navarria P, Collini P, Gronchi A, Olmi P, Fossati-Bellani F, Casali PG. Rhabdomyosarcoma in adults. A retrospective analysis of 171 patients treated at a single institution. Cancer. 2003;98:571–580. doi: 10.1002/cncr.11550. - DOI - PubMed
-
- Grier HE, Krailo MD, Tarbell NJ, Link MP, Fryer CJ, Pritchard DJ, Gebhardt MC, Dickman PS, Perlman EJ, Meyers PA, Donaldson SS, Moore S, Rausen AR, Vietti TJ, Miser JS. Addition of ifosfamide and etoposide to standard chemotherapy for Ewing’s sarcoma and primitive neuroectodermal tumor of bone. N Engl J Med. 2003;348:694–701. doi: 10.1056/NEJMoa020890. - DOI - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical